| Product Code: ETC13102917 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Plasma Protein Therapeutic Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Plasma Protein Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 China Plasma Protein Therapeutic Market - Industry Life Cycle |
3.4 China Plasma Protein Therapeutic Market - Porter's Five Forces |
3.5 China Plasma Protein Therapeutic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Plasma Protein Therapeutic Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.7 China Plasma Protein Therapeutic Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 China Plasma Protein Therapeutic Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 China Plasma Protein Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring plasma protein therapeutics |
4.2.2 Growing healthcare expenditure and government support for healthcare infrastructure in China |
4.2.3 Rising awareness about the benefits of plasma protein therapeutics |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for plasma protein therapeutics in China |
4.3.2 Competition from alternative therapies and generic products |
4.3.3 High cost associated with plasma protein therapeutics |
5 China Plasma Protein Therapeutic Market Trends |
6 China Plasma Protein Therapeutic Market, By Types |
6.1 China Plasma Protein Therapeutic Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Plasma Protein Therapeutic Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 China Plasma Protein Therapeutic Market Revenues & Volume, By Immunoglobulins, 2021 - 2031F |
6.1.4 China Plasma Protein Therapeutic Market Revenues & Volume, By Albumin, 2021 - 2031F |
6.1.5 China Plasma Protein Therapeutic Market Revenues & Volume, By Clotting Factors, 2021 - 2031F |
6.1.6 China Plasma Protein Therapeutic Market Revenues & Volume, By Alpha-1 Antitrypsin, 2021 - 2031F |
6.1.7 China Plasma Protein Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 China Plasma Protein Therapeutic Market, By Source |
6.2.1 Overview and Analysis |
6.2.2 China Plasma Protein Therapeutic Market Revenues & Volume, By Human Plasma, 2021 - 2031F |
6.2.3 China Plasma Protein Therapeutic Market Revenues & Volume, By Blood Plasma, 2021 - 2031F |
6.2.4 China Plasma Protein Therapeutic Market Revenues & Volume, By Factor VIII, IX, 2021 - 2031F |
6.2.5 China Plasma Protein Therapeutic Market Revenues & Volume, By Genetic Plasma, 2021 - 2031F |
6.2.6 China Plasma Protein Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 China Plasma Protein Therapeutic Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 China Plasma Protein Therapeutic Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 China Plasma Protein Therapeutic Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 China Plasma Protein Therapeutic Market Revenues & Volume, By Hemophilia Centers, 2021 - 2031F |
6.3.5 China Plasma Protein Therapeutic Market Revenues & Volume, By Research Labs, 2021 - 2031F |
6.3.6 China Plasma Protein Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
6.4 China Plasma Protein Therapeutic Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 China Plasma Protein Therapeutic Market Revenues & Volume, By Immune Deficiency Treatment, 2021 - 2031F |
6.4.3 China Plasma Protein Therapeutic Market Revenues & Volume, By Liver & Kidney Disorders, 2021 - 2031F |
6.4.4 China Plasma Protein Therapeutic Market Revenues & Volume, By Blood Disorder Management, 2021 - 2031F |
6.4.5 China Plasma Protein Therapeutic Market Revenues & Volume, By Rare Diseases, 2021 - 2031F |
6.4.6 China Plasma Protein Therapeutic Market Revenues & Volume, By Others, 2021 - 2031F |
7 China Plasma Protein Therapeutic Market Import-Export Trade Statistics |
7.1 China Plasma Protein Therapeutic Market Export to Major Countries |
7.2 China Plasma Protein Therapeutic Market Imports from Major Countries |
8 China Plasma Protein Therapeutic Market Key Performance Indicators |
8.1 Number of clinical trials for new plasma protein therapeutics in China |
8.2 Investment in research and development for plasma protein therapeutics in China |
8.3 Patient adherence and compliance rates for plasma protein therapeutic treatments |
9 China Plasma Protein Therapeutic Market - Opportunity Assessment |
9.1 China Plasma Protein Therapeutic Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Plasma Protein Therapeutic Market Opportunity Assessment, By Source, 2021 & 2031F |
9.3 China Plasma Protein Therapeutic Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 China Plasma Protein Therapeutic Market Opportunity Assessment, By Application, 2021 & 2031F |
10 China Plasma Protein Therapeutic Market - Competitive Landscape |
10.1 China Plasma Protein Therapeutic Market Revenue Share, By Companies, 2024 |
10.2 China Plasma Protein Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here